doi: 10.1042/CS20060307 147 BhandariBSubramanianL
Individuals taking the drugs for diabetes were more likely to restart the medication compared with those using them for obesity, a difference associated with more consistent insurance coverage for diabetes-related prescriptions
NVO: The Market Leaders There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)
Best for: Nagging gym injuries, tendonitis, ligament issues, or gut health problems
Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ
NAD+ for Improved Overall Health Although we only administer NAD+ on its own, we still recommend it as part of a comprehensive treatment plan to restore energy